← Browse by Condition
Medical Condition
er breast cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 2
NCT06395519 Phase 1, Phase 2
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
NCT07483307 Phase 2
Recruiting
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer
Enrollment
176 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT07002177 Phase 1, Phase 2
Recruiting
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Enrollment
196 pts
Location
China
Sponsor
Forward Pharmaceuticals Co., L...